Abiopharma

🔍 Mack Gene (Director)

Company: Gain Therapeutics, Inc. (GANX)

Report Date: 2026-03-24

Detailed Transactions and Holdings:

• Acquired 200,000 shares of Employee Stock Option (right to buy) at $1.86 per share (Derivative)
  Date: 2026-03-24 | Code: A | Expires: 2036-03-24 | equity_swap_involved: 0 | shares_owned_after: 200,000.00 | transaction_form_type: 4 | Footnotes: F1

Footnotes:

• F1: The shares underlying the option shall vest as to 25% on March 24, 2027, and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date.